Assyro AI

FDA Orange Book · active-ingredient family

Ibuprofen; pseudoephedrine hydrochloride

Ibuprofen; pseudoephedrine hydrochloride is approved as 5 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

5

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, suspension, tablet

ProductApplicantApplicationTEApproved
ADVIL COLD AND SINUSRLDHALEON US HOLDINGSNDA 021374May 30, 2002
CHILDREN'S MOTRIN COLDRLDKENVUE BRANDSNDA 021128Aug 01, 2000
ADVIL COLD AND SINUSRLDHALEON US HOLDINGSNDA 019771Sep 19, 1989
CHILDREN'S ADVIL COLDHALEON US HOLDINGSNDA 021373Apr 18, 2002
SINE-AID IBKENVUE BRANDSNDA 019899Dec 31, 1992

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDEAUROBINDO PHARMA LTDANDA 213565Mar 10, 2023
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDEAUROBINDO PHARMAANDA 209235Dec 01, 2017
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDESTRIDES PHARMAANDA 077628Aug 14, 2006
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDEPERRIGOANDA 076478Nov 05, 2003
IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDECONTRACT PHARMACALANDA 075588Apr 08, 2002
IBUPROHM COLD AND SINUSOHM LABSANDA 074567Apr 17, 2001

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ibuprofen; pseudoephedrine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.